PG15 EVALUATION OF THE COST-EFFECTIVENESS OF CONCOMITANT ORAL AND TOPICAL MESALAZINE TREATMENT VERSUS ORAL TREATMENT ALONE IN MILD-TO-MODERATE ACTIVE ULCERATIVE COLITIS- A DECISION-ANALYTIC MODEL
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65255-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65255-2/fulltext
Section Title :
Section Order :
416
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65255-2&doi=10.1016/S1098-3015(10)65255-2